Thirty Madison vs Ro

Side-by-side comparison of model-estimated upside.

Thirty Madison

-55%

est. 2Y upside i

Healthcare

Rank

#2650

Sector

HealthTech

Est. Liquidity

~2Y

Data Quality

Data: Medium

The combined Remedy Meds and Thirty Madison entity operates in a fast-growing digital health market, with Remedy Meds generating over $450M in revenue and Thirty Madison over $220M, both profitable.

Last updated: March 10, 2026

Ro

-69%

est. 2Y upside i

Healthcare

Rank

#2812

Sector

Telehealth/Consumer Health

Est. Liquidity

~3Y

Data Quality

Data: Medium

Ro: Moderate Upside with 30% expected upside.

Last updated: March 22, 2026

Note: These companies have different risk levels. Thirty Madison (Higher Risk) and Ro (Moderate Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.

Upside Comparison

Expected Upside

Thirty Madison

-55%

-69%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.